Yawei Wang

Shenyang, 110042, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.

YB1 regulates miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in hepatocellular carcinoma.

Journal: Cancer communications (London, England)

Published: January 27, 2021

Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction Network.

Identification and Characterization of Robust Hepatocellular Carcinoma Prognostic Subtypes Based on an Integrative Metabolite-Protein Interaction Network.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 25, 2021

Clinical application of enhanced recovery after surgery (ERAS) in pectus excavatum patients following Nuss procedure.

Clinical application of enhanced recovery after surgery (ERAS) in pectus excavatum patients following Nuss procedure.

Journal: Journal of thoracic disease

Published: July 10, 2020

Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.

Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 18, 2020

Long noncoding RNA PURPL promotes cell proliferation in liver cancer by regulating p53.

Long noncoding RNA PURPL promotes cell proliferation in liver cancer by regulating p53.

Journal: Molecular medicine reports

Published: August 01, 2018

Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.

Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.

Journal: Oncotarget

Published: November 30, 2016

MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.

MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 17, 2016

Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma.

Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma.

Journal: BMC cancer

Published: August 31, 2014

Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.

Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.

Journal: International journal of oncology

Published: February 13, 2014

[Retracted] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.

[Retracted] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.

Journal: International journal of oncology

Published: February 13, 2014

miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.

miR-372 down-regulates the oncogene ATAD2 to influence hepatocellular carcinoma proliferation and metastasis.

Journal: BMC cancer

Published: September 26, 2013

Low RIN1 expression in HCC is associated with tumor invasion and unfavorable prognosis.

Low RIN1 expression in HCC is associated with tumor invasion and unfavorable prognosis.

Journal: American journal of clinical pathology

Published: June 15, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026